TUMORGENESIS Trademark

Trademark Overview

On Thursday, May 9, 2019, a trademark application was filed for TUMORGENESIS with the United States Patent and Trademark Office. The USPTO has given the TUMORGENESIS trademark a serial number of 88423542. The federal status of this trademark filing is REGISTERED as of Tuesday, October 13, 2020. This trademark is owned by Precision Therapeutics Inc.. The TUMORGENESIS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical research services in the nature of providing cancer diagnostic and prognostic services, namely, growing cancer cells in tissue culture and assessing the cells for diagnostic and prognostic purposes
tumorgenesis

General Information

Serial Number88423542
Word MarkTUMORGENESIS
Filing DateThursday, May 9, 2019
Status700 - REGISTERED
Status DateTuesday, October 13, 2020
Registration Number6176896
Registration DateTuesday, October 13, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Pseudo MarkTUMOR GENESIS
Goods and ServicesMedical research services in the nature of providing cancer diagnostic and prognostic services, namely, growing cancer cells in tissue culture and assessing the cells for diagnostic and prognostic purposes

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, May 24, 2019
Primary Code042
First Use Anywhere DateTuesday, April 30, 2019
First Use In Commerce DateThursday, June 11, 2020

Trademark Owner History

Party NamePREDICTIVE ONCOLOGY INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressEagan, MN 55121
Party NamePREDICTIVE ONCOLOGY INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressEAGAN, MN 55121
Party NamePrecision Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressEagan, MN 55121

Trademark Events

Event DateEvent Description
Wednesday, July 24, 2019ASSIGNED TO EXAMINER
Monday, July 29, 2019NON-FINAL ACTION WRITTEN
Monday, May 13, 2019NEW APPLICATION ENTERED
Friday, May 24, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, February 12, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, February 14, 2020NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, July 29, 2019NON-FINAL ACTION E-MAILED
Monday, July 29, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, January 29, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 29, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 30, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 14, 2020FINAL REFUSAL WRITTEN
Friday, February 14, 2020FINAL REFUSAL E-MAILED
Friday, August 14, 2020TEAS AMENDMENT OF USE RECEIVED
Friday, August 14, 2020TEAS REQUEST FOR RECONSIDERATION RECEIVED
Saturday, August 15, 2020USE AMENDMENT FILED
Saturday, August 15, 2020AMENDMENT TO USE PROCESSING COMPLETE
Friday, August 14, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, August 15, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 27, 2020APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Friday, August 28, 2020NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Wednesday, September 2, 2020ASSIGNED TO LIE
Wednesday, September 9, 2020LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, October 13, 2020REGISTERED-SUPPLEMENTAL REGISTER
Tuesday, January 2, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, January 2, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, January 2, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, January 2, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, October 13, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, January 2, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 27, 2020USE AMENDMENT ACCEPTED
Tuesday, January 2, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

tumorgenesis diagnostic cells cancer prognostic services tissue culture assessing research purposes